Readings Newsletter
Become a Readings Member to make your shopping experience even easier.
Sign in or sign up for free!
You’re not far away from qualifying for FREE standard shipping within Australia
You’ve qualified for FREE standard shipping within Australia
The cart is loading…
Protein Kinase Inhibitors: The Promise of Natural Products in Cancer Therapeutics offers an in-depth exploration of how nutraceutical-based kinase inhibitors are shaping the future of cancer treatment. The book presents the scientific principles behind the ability of natural products to influence kinase activity, disrupt cancer progression, and open new avenues for therapeutic intervention. Covering both historical context and modern advances, it provides readers-ranging from researchers and healthcare professionals to students-with a comprehensive understanding of the mechanisms and clinical relevance of natural CDK inhibitors, emphasizing their growing significance in oncology.
The book also highlights polyphenolic derivatives and other natural compounds that target key kinases in major cancer signaling pathways. It features insights into topics such as polyphenols' roles in cancer management, new sources of breast cancer inhibitors, and natural products in lymphoma therapy. With chapters dedicated to the multitarget potential of phytochemicals and practical applications in clinical trials, this resource bridges scientific research and clinical practice, inspiring innovation in structure-based drug design and advancing the use of nature-derived therapeutics in cancer care.
$9.00 standard shipping within Australia
FREE standard shipping within Australia for orders over $100.00
Express & International shipping calculated at checkout
Protein Kinase Inhibitors: The Promise of Natural Products in Cancer Therapeutics offers an in-depth exploration of how nutraceutical-based kinase inhibitors are shaping the future of cancer treatment. The book presents the scientific principles behind the ability of natural products to influence kinase activity, disrupt cancer progression, and open new avenues for therapeutic intervention. Covering both historical context and modern advances, it provides readers-ranging from researchers and healthcare professionals to students-with a comprehensive understanding of the mechanisms and clinical relevance of natural CDK inhibitors, emphasizing their growing significance in oncology.
The book also highlights polyphenolic derivatives and other natural compounds that target key kinases in major cancer signaling pathways. It features insights into topics such as polyphenols' roles in cancer management, new sources of breast cancer inhibitors, and natural products in lymphoma therapy. With chapters dedicated to the multitarget potential of phytochemicals and practical applications in clinical trials, this resource bridges scientific research and clinical practice, inspiring innovation in structure-based drug design and advancing the use of nature-derived therapeutics in cancer care.